Below is an image of an Eli Lilly letter which informs doctors in the UK that Prozac is no longer authorized for use in (so-called) premenstrual dysphoric disorder (PMDD). For a larger view, please click on the image.
U.K. Government Issues New Warnings Re: Use of antidepressant drugs for children Sept. 2003 note: click on text image for larger picture related link: Sept 23, 2003 infomail
"It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine." Marcia Angell, MD
Use of combinations of antipsychotics–Harms Patients: McLean & Leipzig Wed, 21 Sep 2005 Two additional studies provide additional evidence (coffin nails) demonstrating how psychiatry’s marriage of convenience gave birth to rotten fruit: specifically, under the influence of pharmaceutical companies, psychiatry plunged irresponsibly into practicing polypsychoparmacology. The evidence from these studies…
The $$$ amounts–one might call them, "fees for services rendered"–reveal the truth about who wields the greatest influence on NAMI policies–and whose interests are being served by NAMI.
The New York Times HEADLINE: Experiments On Children Are Reviewed By PHILIP J. HILTS Federal research-ethics officials are investigating several psychiatric experiments in which 100 New York City boys, many of them black or Hispanic, were given the now-banned diet drug fenfluramine. The three experiments took place at the New…
Institute of Medicine (IOM) Panel Misses the Point re Test Subjects October 3, 2002 See also the following Institute of Medicine of the National Academy of Sciences documents: IOM Report: Responsible Research: A Systems Approach to Protecting Research Participants. Oct. 3, 2002 (Adobe Acrobat document) IOM Public Briefing – October…
